bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 29, 2024
Abstract
Cellular
senescence
features
a
durable
exit
from
the
cell
cycle
triggered
by
stress
or
carcinogens.
The
INK4
locus
is
inactivated
in
various
cancers,
yet
senescence,
p16
Ink4a
activated.
Whether
tumor-suppressing
-promoting
remains
conundrum.
We
discovered
an
evolutionally-conserved
Vertebrata
INK4-homolog.
This
ink4ab
triggers
upon
oxidative-
and/or
carcinogenic-stress.
Adult
Ink4ab-deficient
animals
failed
to
activate
and
developed
spontaneous
cancers.
Combined
Ink4ab
Tp53
deficiency
revealed
reciprocal
apoptosis
regulation,
controlling
tumorigenesis,
including
retinoblastoma.
INK4-hematopoietic-deficient
mice
exhibited
p19
Arf
-dependent
enhanced
senescence-like
phenotypes,
uncontrolled
proliferation,
defective
stem
differentiation,
splenomegaly,
with
single-splenocytes
spatially-enriched
senescence-associated
secretory
profiles.
Our
studies
reveal
evolutionary
origin
of
paradigms
co-regulating
tumor
suppression
offer
strategies
exploit
these
pathways
for
cancer
prevention
therapy.
Cell,
Год журнала:
2024,
Номер
187(16), С. 4150 - 4175
Опубликована: Авг. 1, 2024
Cellular
senescence
is
a
cell
fate
triggered
in
response
to
stress
and
characterized
by
stable
cell-cycle
arrest
hypersecretory
state.
It
has
diverse
biological
roles,
ranging
from
tissue
repair
chronic
disease.
The
development
of
new
tools
study
vivo
paved
the
way
for
uncovering
its
physiological
pathological
roles
testing
senescent
cells
as
therapeutic
target.
However,
lack
specific
broadly
applicable
markers
makes
it
difficult
identify
characterize
tissues
living
organisms.
To
address
this,
we
provide
practical
guidelines
called
"minimum
information
cellular
experimentation
vivo"
(MICSE).
presents
an
overview
rodent
tissues,
transgenic
models,
non-mammalian
systems,
human
tumors
their
use
identification
specification
cells.
These
uniform,
state-of-the-art,
accessible
toolset
improve
our
understanding
vivo.
The Journal of Experimental Medicine,
Год журнала:
2024,
Номер
221(4)
Опубликована: Фев. 22, 2024
Cellular
senescence
is
a
critical
stress
response
program
implicated
in
embryonic
development,
wound
healing,
aging,
and
immunity,
it
backs
up
apoptosis
as
an
ultimate
cell-cycle
exit
mechanism.
In
analogy
to
replicative
exhaustion
of
telomere-eroded
cells,
premature
types
senescence—referring
oncogene-,
therapy-,
or
virus-induced
senescence—are
widely
considered
irreversible
growth
arrest
states
well.
We
discuss
here
that
entry
into
full-featured
not
necessarily
permanent
endpoint,
but
dependent
on
essential
maintenance
components,
potentially
transient.
Unlike
binary
state
switch,
we
view
with
its
extensive
epigenomic
reorganization,
profound
cytomorphological
remodeling,
distinctive
metabolic
rewiring
rather
journey
toward
condition
variable
strength
depth.
Senescence-underlying
maintenance-essential
molecular
mechanisms
may
allow
reentry
if
continuously
provided.
Importantly,
senescent
cells
resumed
proliferation
fundamentally
differ
from
those
never
entered
senescence,
hence
would
reflect
reversion
dynamic
progression
post-senescent
comes
distinct
functional
clinically
relevant
ramifications.
The
intricate
relationship
between
cancer,
circadian
rhythms,
and
aging
is
increasingly
recognized
as
a
critical
factor
in
understanding
the
mechanisms
underlying
tumorigenesis
cancer
progression.
Aging
well-established
primary
risk
for
while
disruptions
rhythms
are
intricately
associated
with
progression
of
various
tumors.
Moreover,
itself
disrupts
leading
to
physiological
changes
that
may
accelerate
development.
Despite
these
connections,
specific
interplay
processes
their
collective
impact
on
remains
inadequately
explored
literature.
In
this
review,
we
systematically
explore
influence
We
discuss
how
core
genes
tumor
prognosis,
highlighting
shared
hallmarks
such
genomic
instability,
cellular
senescence,
chronic
inflammation.
Furthermore,
examine
aging,
focusing
crosstalk
contributes
tumorigenesis,
proliferation,
apoptosis,
well
metabolism
stability.
By
elucidating
common
pathways
linking
review
provides
new
insights
into
pathophysiology
identifies
potential
therapeutic
strategies.
propose
targeting
regulation
could
pave
way
novel
treatments,
including
chronotherapy
antiaging
interventions,
which
offer
important
benefits
clinical
management
cancer.
Cellular
senescence,
a
stable
state
of
cell
cycle
arrest
induced
by
various
stressors
or
genomic
damage,
is
recognized
as
hallmark
cancer.
It
exerts
context-dependent
dual
role
in
cancer
initiation
and
progression,
functioning
tumor
suppressor
promoter.
The
complexity
senescence
arises
from
its
mechanistic
diversity,
potential
reversibility,
heterogeneity.
A
key
mediator
these
effects
the
senescence-associated
secretory
phenotype
(SASP),
repertoire
bioactive
molecules
that
influence
microenvironment
(TME)
remodeling,
modulate
behavior,
contribute
to
therapeutic
resistance.
Given
intricate
biology,
presents
both
challenges
opportunities
for
intervention.
Strategies
targeting
pathways,
including
senescence-inducing
therapies
senolytic
approaches,
offer
promising
avenues
treatment.
This
review
provides
comprehensive
analysis
regulatory
mechanisms
governing
cellular
tumors.
We
also
discuss
emerging
strategies
highlighting
novel
opportunities.
deeper
understanding
processes
essential
developing
precision
improving
clinical
outcomes.
Abstract
Cellular
senescence
is
a
state
of
permanent
growth
arrest.
It
can
be
triggered
by
telomere
shortening
(replicative
senescence)
or
prematurely
induced
stresses
such
as
DNA
damage,
oncogene
overactivation,
loss
tumor
suppressor
genes,
oxidative
stress,
tissue
factors,
and
others.
Advances
in
techniques
experimental
designs
have
provided
new
evidence
about
the
biology
senescent
cells
(SnCs)
their
importance
human
health
disease.
This
review
aims
to
describe
main
aspects
SnCs
phenotype
focusing
on
alterations
subcellular
compartments
like
plasma
membrane,
cytoskeleton,
organelles,
nuclei.
We
also
discuss
heterogeneity,
dynamics,
plasticity
SnCs'
phenotype,
including
SASP,
pro‐survival
mechanisms.
advance
multiple
layers
phenotypic
heterogeneity
SnCs,
between
inducers,
tissues
within
population
discussing
relevance
these
raise
challenges
well
alternatives
overcome
them.
Ultimately,
we
present
open
questions
perspectives
understanding
from
perspective
basic
applied
questions.
Abstract
Non-small
cell
lung
cancer
(NSCLC)
constitutes
one
of
the
deadliest
and
most
common
malignancies.
The
LKB1/STK11
tumour
suppressor
is
mutated
in
∼
30%
NSCLCs,
typically
adenocarcinomas
(LUAD).
We
implemented
zebrafish
human
organoids
as
synergistic
platforms
to
pre-clinically
screen
for
metabolic
compounds
selectively
targeting
LKB1-deficient
tumours.
Interestingly,
two
kinase
inhibitors,
Piceatannol
Tyrphostin
23,
appeared
exert
synthetic
lethality
with
LKB1
mutations.
Although
loss
alone
accelerates
energy
expenditure,
unexpectedly
we
find
that
it
additionally
alters
regulation
key
homeostasis
maintenance
player
leptin
(LEP),
further
increasing
energetic
burden
exposing
a
vulnerable
point;
acquired
sensitivity
identified
compounds.
show
compound
treatment
stabilises
Hypoxia-inducible
factor
1-alpha
(HIF1A)
by
antagonising
Von
Hippel-Lindau
(VHL)-mediated
HIF1A
ubiquitination,
driving
LEP
hyperactivation.
Importantly,
demonstrate
piceatannol/tyrphostin
23
epistatically
relies
on
HIF1A-LEP-Uncoupling
Protein
2
(UCP2)
signaling
axis
lowering
cellular
beyond
survival,
already
challenged
cells.
Thus,
uncover
pivotal
vulnerability
tumours,
which
may
be
therapeutically
exploited
using
our
mitochondrial
uncouplers.
Cells,
Год журнала:
2024,
Номер
13(15), С. 1281 - 1281
Опубликована: Июль 30, 2024
Cellular
senescence
has
been
increasingly
recognized
as
a
hallmark
of
cancer,
reflecting
its
association
with
aging
and
inflammation,
role
response
to
deregulated
proliferation
oncogenic
stress,
induction
by
cancer
therapies.
While
therapy-induced
(TIS)
linked
resistance,
recurrence,
metastasis,
normal
tissue
toxicity,
TIS
also
the
potential
enhance
therapy
stimulate
anti-tumor
immunity.
In
this
review,
we
examine
Jekyll
Hyde
nature
senescent
cells
(SnCs),
focusing
on
how
their
persistence
while
expressing
senescence-associated
secretory
phenotype
(SASP)
modulates
tumor
microenvironment
through
autocrine
paracrine
mechanisms.
Through
SASP,
SnCs
can
mediate
both
resistance
To
fulfill
unmet
immunotherapy,
consider
may
influence
inflammation
serve
an
antigen
source
potentiate
immune
response.
This
new
perspective
suggests
treatment
approaches
based
checkpoint
blockade.
Finally,
describe
strategies
for
mitigating
detrimental
effects
senescence,
such
modulating
SASP
or
targeting
SnC
persistence,
which
overall
benefits
treatment.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(5), С. 2473 - 2473
Опубликована: Фев. 20, 2024
The
currently
available
anti-cancer
therapies,
such
as
gamma-radiation
and
chemotherapeutic
agents,
induce
cell
death
cellular
senescence
not
only
in
cancer
cells
but
also
the
adjacent
normal
tissue.
New
anti-tumor
approaches
focus
on
limiting
side
effects
cells.
In
this
frame,
potential
properties
of
Pulsed
Electromagnetic
Fields
(PEMFs)
through
irradiation
breast
epithelial
(MCF-7
MDA-MB-231)
fibroblasts
(FF95)
were
investigated.
PEMFs
had
a
frequency
8
Hz,
full-square
wave
type
magnetic
flux
density
0.011
T
applied
twice
daily
for
5
days.
data
collected
showcase
that
PEMF
application
decreases
proliferation
rate
viability
while
having
opposite
effect
fibroblasts.
Moreover,
induces
without
any
non-cancerous
These
findings
suggest
novel,
non-invasive
strategy
that,
when
combined
with
senolytic
drugs,
may
eliminate
both
remaining
senescent
cells,
simultaneously
avoiding
current
treatments.
STAR Protocols,
Год журнала:
2024,
Номер
5(1), С. 102929 - 102929
Опубликована: Март 1, 2024
Identification
and
isolation
of
senescent
cells
is
challenging,
rendering
their
detailed
analysis
an
unmet
need.
We
describe
a
precise
one-step
protocol
to
fluorescently
label
cells,
for
flow
cytometry
fluorescence
microscopy,
implementing
fluorophore-conjugated
Sudan
Black-B
analog,
GLF16.
Also,
micelle-based
approach
allows
identification
in
vivo
vitro,
enabling
live-cell
sorting
downstream
analyses
live
tracking.
Our
protocols
are
applicable
cellular
systems,
tissues,
or
animal
models
where
senescence
present.
For
complete
details
on
the
use
execution
this
protocol,
please
refer
Magkouta
et
al.1